Page last updated: 2024-08-18

phenylisothiocyanate and B16 Melanoma

phenylisothiocyanate has been researched along with B16 Melanoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kuttan, G; Thejass, P	1

Other Studies

1 other study(ies) available for phenylisothiocyanate and B16 Melanoma

Article	Year
Inhibition of endothelial cell differentiation and proinflammatory cytokine production during angiogenesis by allyl isothiocyanate and phenyl isothiocyanate. Integrative cancer therapies, 2007, Volume: 6, Issue:4 Topics: Angiogenesis Inhibitors; Animals; Cell Differentiation; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cytokines; Endothelial Cells; Fibroblast Growth Factors; Gene Expression; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukins; Isothiocyanates; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Tissue Inhibitor of Metalloproteinase-1; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A	2007

Article

Year

Inhibition of endothelial cell differentiation and proinflammatory cytokine production during angiogenesis by allyl isothiocyanate and phenyl isothiocyanate.

Integrative cancer therapies, 2007, Volume: 6, Issue:4

Topics: Angiogenesis Inhibitors; Animals; Cell Differentiation; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cytokines; Endothelial Cells; Fibroblast Growth Factors; Gene Expression; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukins; Isothiocyanates; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Tissue Inhibitor of Metalloproteinase-1; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A

2007